PILOT™ Steering Committee

Program Chairperson

Paul W. Noble, MD

Committee Members

Jeffrey A. Golden, MD	Glenn D. Rosen, MD
Kevin O. Leslie, MD	Steven A. Sahn, MD
Steven D. Nathan, MD	W. Richard Webb, MD
Maria L. Padilla, MD

Disclosure Statement

The France Foundation relies upon faculty members to provide educational information in a manner that is objective and free from bias. In compliance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Commercial Support, all faculty members are asked to disclose any conflicts of interest related to the context of their participation in a CME activity. Faculty members have disclosed the following relationships with commercial interests:

Paul W. Noble, MD, has served as a consultant for Genzyme Corporation, InterMune, and Millennium Pharmaceuticals, Inc. He served on a scientific advisory board for ICOS and has received research grants from the National Institutes of Health.

Jeffrey A. Golden, MD, has nothing to disclose.

Kevin O. Leslie, MD, has received speaking honoraria from InterMune.

Steven D. Nathan, MD, has served as a consultant, has served on a speakers bureau, and has received grant support from InterMune, and has received research funding from Novartis and Wyeth.

Maria L. Padilla, MD, has served as a speaker and consultant for InterMune.

Glenn D. Rosen, MD, has served as a speaker and has served on advisory boards for InterMune.

Steven A. Sahn, MD, has served on an advisory board, and has served as a speaker and investigator for InterMune.

W. Richard Webb, MD, has served on a pulmonary advisory board for InterMune.

Contributing Faculty

Kevin K. Brown, MD	Imre Noth, MD
James H. Dauber, MD	Ganesh Raghu, MD, FACP, FCCP
Kevin R. Flaherty, MD, MS	Marvin I. Schwarz, MD
Robert J. Homer, MD, PhD	Charlie Strange, MD
David Lynch, MD	Robert M. Strieter, MD
Yolanda N. Mageto, MD	David A. Zisman, MD
Fernando J. Martinez, MD, MS

Kevin K. Brown, MD, has served as a consultant for Actelion, Arizeke, Encysive, FibroGen, Genzyme, InterMune, and Wyeth.

James H. Dauber, MD, has served on speakers bureaus and on advisory boards for InterMune.

Kevin R. Flaherty, MD, MS, has nothing to disclose.

Robert J. Homer, MD, PhD, has nothing to disclose.

David Lynch, MD, has served as a consultant for InterMune.

Yolanda N. Mageto, MD, has served on the speakers bureau for InterMune.

Fernando J. Martinez, MD, MS, has served a consultant and on speakers bureaus for Aventis Pharmaceuticals Inc, Boehringer Ingelheim, GlaxoSmithKline, InterMune, Ortho-McNeil, and Pfizer Inc.

Imre Noth, MD, has served as a clinical investigator for InterMune.

Ganesh Raghu, MD, FACP, FCCP, serves as an advisor, consultant, and clinical trial investigator for Actelion, FibroGen, Genzyme, InterMune, and Shionogi.

Marvin I. Schwarz, MD, has nothing to disclose.

Charlie Strange, MD, has received grant support from Actelion, CoTherix, and Encysive. He has served as a consultant for InterMune.

Robert M. Strieter, MD, has served as a consultant for InterMune.

David A. Zisman, MD, has received research grants and honoraria from InterMune and has received research grants from Actelion and Wyeth.

Disclaimer

The opinions, recommendations, and guidelines expressed herein are those of the PILOT™ Steering Committee and other contributing faculty, and not necessarily those of The France Foundation or InterMune, who assume no responsibility or liability for the material that appears herein.